Inogen (INGN) Now a Strong Buy on Positive 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 5:11PM CST
On Dec 18, 2014, Zacks Investment Research upgraded home care oxygen therapy provider Inogen Inc (INGN) to a Zacks Rank #1 (Strong Buy).
PHG: 29.39 (-0.06), IVC: 16.80 (+0.20), INGN: 29.99 (-0.09), SURG: 4.39 (-0.03)
Synergetics (SURG) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 8:29AM CST
Synergetics (SURG) Shares March Higher, Can It Continue?
SURG: 4.39 (-0.03)
Synergetics USA (SURG) Jumps: Stock Adds 9.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:30AM CST
Synergetics USA, Inc. (SURG) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.40 (-0.01), FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), SURG: 4.39 (-0.03)
Synergetics ups revenues 7% in FQ1
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 6:51AM CST
SURG: 4.39 (-0.03)
Synergetics buys UK based Sterimedix for USD13.5m
M2 - Thu Dec 11, 6:21AM CST
Medical device company Synergetics USA (NASDAQ:SURG) reported on Wednesday the completion of the acquisition of Sterimedix for a net cash consideration of USD13.5m.
SURG: 4.39 (-0.03)
Synergetics' (SURG) CEO Dave Hable on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Dec 10, 10:05PM CST
SURG: 4.39 (-0.03)
Synergetics posts 1Q profit
Automated Insights - Wed Dec 10, 3:48PM CST
O`FALLON, Mo. (AP) _ Synergetics USA Inc. (SURG) on Wednesday reported net income of $768,000 in its fiscal first quarter.
SURG: 4.39 (-0.03)
Synergetics misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 3:13PM CST
SURG: 4.39 (-0.03)
Synergetics Reports First Quarter of Fiscal Year 2015 Results
Marketwired - Wed Dec 10, 3:05PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced results for the first quarter of fiscal year 2015.
SURG: 4.39 (-0.03)
Synergetics Acquires U.K.-Based Manufacturer Sterimedix Ltd.
Marketwired - Wed Dec 10, 3:01PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced it has acquired Sterimedix Limited ("Sterimedix"
SURG: 4.39 (-0.03)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 4:35PM CST
SIGM: 5.58 (+0.06), RH: 96.97 (-0.16), MW: 43.78 (-0.24), IRET: 8.46 (-0.11), CENT: 8.66 (+0.06), AVNW: 1.52 (+0.01), WTSL: 0.06 (-0.02), PPHM: 1.40 (+0.01), CASY: 89.15 (+0.12), SURG: 4.39 (-0.03)
Synergetics reports December 10
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 8:48AM CST
SURG: 4.39 (-0.03)
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2015 Results
Marketwired - Mon Dec 01, 9:30PM CST
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Wednesday, December 10, 2014 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal first quarter ended October 31, 2014. A news release announcing the first quarter's results will be issued on Wednesday, December 10, 2014, after market close.
SURG: 4.39 (-0.03)
Synergetics Reports Fourth Quarter and Fiscal Year 2014 Results
Marketwired - Tue Oct 14, 3:34PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced results for the fourth quarter and fiscal year ended July 31, 2014.
SURG: 4.39 (-0.03)
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2014 Results
Marketwire - Wed Oct 01, 7:01AM CDT
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Tuesday, October 14, 2014 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal fourth quarter and fiscal year ended July 31, 2014. A news release announcing the fourth quarter and fiscal year results will be issued on Tuesday, October 14, 2014, after market close.
SURG: 4.39 (-0.03)
Synergetics to Participate in Baird 2014 Health Care Conference
Marketwire - Tue Aug 26, 7:02AM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced plans to participate in the Baird 2014 Health Care Conference at the New York Palace Hotel in New York, New York.
SURG: 4.39 (-0.03)
Institutional Investor Share of U.S. Residential Purchases in January Drops to Lowest Level Since March 2012
Marketwire - Wed Feb 26, 11:01PM CST
RealtyTrac(R) (www.realtytrac.com), the nation's leading source for comprehensive housing data, today released its January 2014 Residential & Foreclosure Sales Report, which shows that institutional investors -- defined as entities purchasing at least 10 properties in a calendar year -- accounted for 5.2 percent of all U.S. residential property sales in January, down from 7.9 percent in December and down from 8.2 percent in January 2013.
SURG: 4.39 (-0.03)